Resources

Selected
  • Systematic reviews (SYSVAC)
Type of publications
Regions
Diseases
Vaccine topics
Target population
Publication date
2750 results found
2023 ∙ Pratiwi, A. Setyoboedi, B. Wungu, C. D. K.
Factors Affecting the Long-Term Protection Against Hepatitis B Immunization in Infancy: A Meta-Analysis
Newborn Children Adolescents Hepatitis B Efficacy/effectiveness
Rating:
Critically low
2023 ∙ Luo, X. Lessomo, F. Y. N. Yu, Z. Xie, Y.
Factors influencing immunogenicity and safety of SARS-CoV-2 vaccine in liver transplantation recipients: a systematic review and meta-analysis
All age groups COVID-19 Efficacy/effectiveness Safety
Rating:
Critically low
2023 ∙ Dardas, L. A. Al-Leimon, O. Jaber, A. R. Saadeh, M. Al-Leimon, A. Al-Hurani, A. Jaber, A. R. Aziziye, O. Al-Salieby, F. Aljahalin, M. Van de Water, B.
Flu Shots Unveiled: A Global Systematic Review of Healthcare Providers' Uptake of, Perceptions, and Attitudes toward Influenza Vaccination
Healthcare workers Influenza Acceptance
Rating:
Not applicable
2023 ∙ Guglin, M. E. Etuk, A. Shah, C. Ilonze, O. J.
Fulminant Myocarditis and Cardiogenic Shock Following COVID-19 Infection Versus COVID-19 Vaccination: A Systematic Literature Review
Adults Older adults COVID-19 Safety
Rating:
Critically low
2023 ∙ Haslund, M. M. Sorensen, J. K. GraffStensballe, L.
Genetics and measles, mumps and rubella vaccine response in childhood and adolescence-A systematic review
Newborn Children Adolescents Measles Mumps Rubella Efficacy/effectiveness
Rating:
Critically low
2023 ∙ Ekpor, E. Akyirem, S.
Global acceptance of COVID-19 vaccine among persons with diabetes: A systematic review and meta-analysis
All age groups COVID-19 Acceptance
Rating:
Not applicable
2023 ∙ Guo, Y. Cao, X. S. Yang, H. T. Zhou, M. G. Yu, B.
Global incidence pattern and factors associated with common cutaneous reactions related to COVID-19 vaccination of 2.55 million participants in real-world settings: A systematic review and meta-analysis
All age groups Pregnant women Healthcare workers COVID-19 Safety
Rating:
Low
2023 ∙ Reddy, Y. M. Murthy, J. M. Osman, S. Jaiswal, S. K. Gattu, A. K. Pidaparthi, L. Boorgu, S. K. Chavan, R. Ramakrishnan, B. Yeduguri, S. R.
Guillain-Barré syndrome associated with SARS-CoV-2 vaccination: how is it different? a systematic review and individual participant data meta-analysis
Adults Older adults COVID-19 Safety
Rating:
Critically low
2023 ∙ Shaheen, N. Ramadan, A. Nashwan, A. J. Shaheen, A. Ahmad, S. Motawea, K. R. Mohamed, S. Mohamed, R. S. Swed, S. Aiash, H.
Guillain-Barré syndrome following COVID-19 vaccination: An updated systematic review of cases
All age groups COVID-19 Safety
Rating:
Critically low
2023 ∙ Yu, M. Nie, S. Qiao, Y. Ma, Y.
Guillain-Barre syndrome following COVID-19 vaccines: A review of literature
Adults Older adults COVID-19 Safety
Rating:
Critically low
Loading...